logo
logo
logo
logo
  • News
  • Approach
  • ESG
  • Portfolio
  • Team
  • Tech Investments
  • Contact

Themis establishes Scientific Advisory Board of experts in virology and vaccine development

26. February 2018
|In Portfolio News
|By eazee-designstudio

Themis establishes Scientific Advisory Board of experts in virology and vaccine development

26. February 2018
|In Portfolio News
|By eazee-designstudio

Themis has established a Scientific Advisory Board (SAB) with the appointment of Christian W. Mandl, Ph.D., MD, W. Paul Duprex, Ph.D., Stephen J. Thomas, MD and Nadia G. Tornieporth, MD. The newly-formed SAB brings a wealth of experience in molecular virology, viral pathogenesis and vaccine development. The purpose of the SAB will be to advise Themis as it continues to develop its pipeline of urgently needed vaccines and immune system activation approaches.

  • Prev
  • Next

© 2022 Wellington Partners. All rights reserved  |  Imprint  |  Privacy Policy | SFDR Disclosures | PRIIPS

Privacy Preference Center

Privacy Preferences